- Motley Fool•2 days ago
Why billionaire investors are loving Immunomedics, Achaogen, AveXis, Exact Sciences, and Clovis Oncology this year.
- PR Newswire•6 days ago
MADISON, Wis., March 17, 2017 /PRNewswire/ -- Exact Sciences Corp. (EXAS) today announced that, in support of the Company's continued growth plans, it granted restricted stock units covering a total of 85,421 shares of common stock to 77 recently hired non-executive employees under its previously announced inducement grant program. The restricted stock unit awards vest in four equal annual installments beginning on the first anniversary of the grant date. The awards were granted as an inducement material to the recently hired employees entering into employment with the Company in accordance with NASDAQ Marketplace Rule 5635(c)(4). The Company is making this announcement as required by NASDAQ rules.
- Motley Fool•10 days ago
Growing demand for its new colon cancer screening test is fueling investors' excitement.
EXAS : Summary for Exact Sciences Corporation - Yahoo Finance
Exact Sciences Corporation (EXAS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
|Bid||18.12 x 100|
|Ask||25.12 x 500|
|Day's Range||20.01 - 20.99|
|52 Week Range||5.36 - 24.50|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-12.54|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|